173 related articles for article (PubMed ID: 27745917)
21. Chemopreventive effects of metformin on obesity-associated endometrial proliferation.
Zhang Q; Celestino J; Schmandt R; McCampbell AS; Urbauer DL; Meyer LA; Burzawa JK; Huang M; Yates MS; Iglesias D; Broaddus RR; Lu KH
Am J Obstet Gynecol; 2013 Jul; 209(1):24.e1-24.e12. PubMed ID: 23500454
[TBL] [Abstract][Full Text] [Related]
22. Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.
Niraula S; Dowling RJ; Ennis M; Chang MC; Done SJ; Hood N; Escallon J; Leong WL; McCready DR; Reedijk M; Stambolic V; Goodwin PJ
Breast Cancer Res Treat; 2012 Oct; 135(3):821-30. PubMed ID: 22933030
[TBL] [Abstract][Full Text] [Related]
23. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
Wang J; Shi H; Xie Y; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
[TBL] [Abstract][Full Text] [Related]
24. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
25. Metformin protects rat hepatocytes against bile acid-induced apoptosis.
Woudenberg-Vrenken TE; Conde de la Rosa L; Buist-Homan M; Faber KN; Moshage H
PLoS One; 2013; 8(8):e71773. PubMed ID: 23951244
[TBL] [Abstract][Full Text] [Related]
26. NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling.
Zhang Y; Goodfellow R; Li Y; Yang S; Winters CJ; Thiel KW; Leslie KK; Yang B
Gynecol Oncol; 2015 Oct; 139(1):127-33. PubMed ID: 26193427
[TBL] [Abstract][Full Text] [Related]
27. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract][Full Text] [Related]
28. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
[TBL] [Abstract][Full Text] [Related]
29. Metformin modulates PI3K and GLUT4 expression and Akt/PKB phosphorylation in human endometrial stromal cells after stimulation with androgen and insulin.
Ferreira GD; Germeyer A; de Barros Machado A; do Nascimento TL; Strowitzki T; Brum IS; von Eye Corleta H; Capp E
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():157-62. PubMed ID: 24480115
[TBL] [Abstract][Full Text] [Related]
30. Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study.
Dowling RJ; Niraula S; Chang MC; Done SJ; Ennis M; McCready DR; Leong WL; Escallon JM; Reedijk M; Goodwin PJ; Stambolic V
Breast Cancer Res; 2015 Mar; 17(1):32. PubMed ID: 25849721
[TBL] [Abstract][Full Text] [Related]
31. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
[TBL] [Abstract][Full Text] [Related]
32. Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells.
Tosca L; Ramé C; Chabrolle C; Tesseraud S; Dupont J
Reproduction; 2010 Feb; 139(2):409-18. PubMed ID: 19906888
[TBL] [Abstract][Full Text] [Related]
33. Cancer-associated fibroblasts promote proliferation of endometrial cancer cells.
Subramaniam KS; Tham ST; Mohamed Z; Woo YL; Mat Adenan NA; Chung I
PLoS One; 2013; 8(7):e68923. PubMed ID: 23922669
[TBL] [Abstract][Full Text] [Related]
34. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
Wang Y; Yin L; Sun X
J Exp Clin Cancer Res; 2020 Aug; 39(1):169. PubMed ID: 32847606
[TBL] [Abstract][Full Text] [Related]
35. TET1-GPER-PI3K/AKT pathway is involved in insulin-driven endometrial cancer cell proliferation.
Xie BY; Lv QY; Ning CC; Yang BY; Shan WW; Cheng YL; Gu C; Luo XZ; Zhang ZB; Chen XJ; Xi XW; Feng YJ
Biochem Biophys Res Commun; 2017 Jan; 482(4):857-862. PubMed ID: 27889612
[TBL] [Abstract][Full Text] [Related]
36. Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial.
Hadad SM; Coates P; Jordan LB; Dowling RJ; Chang MC; Done SJ; Purdie CA; Goodwin PJ; Stambolic V; Moulder-Thompson S; Thompson AM
Breast Cancer Res Treat; 2015 Feb; 150(1):149-55. PubMed ID: 25682077
[TBL] [Abstract][Full Text] [Related]
37. CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.
Zhang Q; Schmandt R; Celestino J; McCampbell A; Yates MS; Urbauer DL; Broaddus RR; Loose DS; Shipley GL; Lu KH
Gynecol Oncol; 2014 Apr; 133(1):83-9. PubMed ID: 24680596
[TBL] [Abstract][Full Text] [Related]
38. Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.
Hadad S; Iwamoto T; Jordan L; Purdie C; Bray S; Baker L; Jellema G; Deharo S; Hardie DG; Pusztai L; Moulder-Thompson S; Dewar JA; Thompson AM
Breast Cancer Res Treat; 2011 Aug; 128(3):783-94. PubMed ID: 21655990
[TBL] [Abstract][Full Text] [Related]
39. Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma.
Shen Q; Stanton ML; Feng W; Rodriguez ME; Ramondetta L; Chen L; Brown RE; Duan X
Int J Clin Exp Pathol; 2010 Nov; 4(1):13-21. PubMed ID: 21228924
[TBL] [Abstract][Full Text] [Related]
40. The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo.
Schrauwen S; Coenegrachts L; Cattaneo A; Hermans E; Lambrechts D; Amant F
Gynecol Oncol; 2015 Aug; 138(2):378-82. PubMed ID: 26050920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
